proline has been researched along with Carcinoma, Hepatocellular in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (16.36) | 18.7374 |
1990's | 6 (10.91) | 18.2507 |
2000's | 8 (14.55) | 29.6817 |
2010's | 22 (40.00) | 24.3611 |
2020's | 10 (18.18) | 2.80 |
Authors | Studies |
---|---|
Bao, X; Chen, Q; Chen, S; Han, X; Huang, J; Liu, Y; Qiu, Y; Sheng, H; Wang, T; Yin, S; Yu, H; Zhang, C | 1 |
Ding, D; Dong, W; Hou, G; Liu, G; Sun, D; Tian, T; Yang, Y; Zhou, W | 1 |
Abu-Gharbieh, E; Abushawish, KYI; Al-Hroub, HM; Alzoubi, KH; Bustanji, Y; El-Huneidi, W; Elgendy, SM; Giddey, AD; Mousa, M; Omar, HA; Semreen, MH; Soares, NC; Soliman, SSM | 1 |
Adamski, J; Ardanaz, E; Barranco, MR; Bonet, C; Breeur, M; Bueno-de-Mesquita, B; Chirlaque, MD; Dossus, L; Eichelmann, F; Ferrari, P; Grioni, S; Gunter, MJ; Heath, AK; His, M; Jenab, M; Johansson, M; Kaaks, R; Katzke, V; Keski-Rahkonen, P; Keun, H; Key, TJ; Kyrø, C; Laouali, N; Manjer, J; Muller, D; Nøst, TH; Olsen, KS; Overvad, K; Palli, D; Panico, S; Quirós, JR; Rentoft, M; Rinaldi, S; Rothwell, JA; Sacerdote, C; Sandanger, TM; Sandsveden, M; Scalbert, A; Schmidt, JA; Schulze, MB; Severi, G; Tjønneland, A; Travis, RC; Tsilidis, K; Tumino, R; Viallon, V; Vidman, L | 1 |
Bartosch, B; Fedorov, VS; Golikov, MV; Ivanov, AV; Ivanova, ON; Kochetkov, SN; Krasnov, GS; Kudryavtseva, AV; Snezhkina, AV; Valuev-Elliston, VT; Zakirova, NF | 1 |
Biondi, B; Brustolin, L; Fregona, D; Marchiò, L; Nardon, C; Pettenuzzo, N; Pontisso, P; Quarta, S | 1 |
Chow, P; Denil, S; Ding, Z; Ericksen, RE; Escande-Beillard, N; Gruenewald, S; Haegebarth, A; Han, W; Lee, QY; Loh, A; Reversade, B; Steckel, M; Toh, HC; Wai Ho, TS | 1 |
Chung, RT; Holmes, JA | 1 |
Aguilar, H; Asatryan, A; Bondin, M; Cacoub, P; Carvalho, A; Castro, RE; Charafeddine, M; Cohen, DE; Dieterich, D; Felizarta, F; Hu, YB; Khan, N; Marinho, RT; Poordad, F; Siddique, A | 1 |
Chen, X; Yan, N | 1 |
Bondin, M; Brown, A; Burroughs, M; Chayama, K; Dylla, DE; Emmett, A; Feld, JJ; Forns, X; Gordon, SC; Heo, J; Hou, J; Jacobson, IM; Lampertico, P; Marcinak, J; Pol, S; Tatsch, F; Zhang, Z | 1 |
Rostkowska, K; Simon, K; Szymanek-Pasternak, A | 1 |
Fang, C; Gao, P; Geng, P; Guo, L; Hu, C; Li, E; Liu, Y; Sun, M; Tang, L; Wang, C; Wang, J; Wang, Y; Xu, G; Yin, P; Yu, J; Zeng, J; Zhuang, Z | 1 |
Berak, H; Białkowska, J; Bolewska, B; Fleischer-Stępniewska, K; Flisiak, R; Garlicki, A; Janczewska, E; Karpińska, E; Karwowska, K; Nazzal, K; Piekarska, A; Simon, K; Tomasiewicz, K; Tronina, O; Tuchendler, E; Zarębska-Michaluk, D; Łucejko, M | 1 |
Giménez-Manzorro, A; Herranz-Alonso, A; Matilla-Peña, A; Revuelta-Herrero, JL; Sanjurjo-Sáez, M | 1 |
Baicus, C; Constantinescu, I; Diculescu, M; Dumitru, R; Gavrila, D; Istratescu, D; Manuc, M; Manuc, T; Oproiu, A; Preda, CM; Sandra, I; Tieranu, C; Vasilescu, C; Voiosu, T | 1 |
Bublak, R | 1 |
Liu, CJ | 1 |
Bukh, J; Gottwein, JM; Humes, D; Jensen, SB; Li, YP; Ramirez, S | 1 |
Dekio, F; Malik, S; Wen, JW | 1 |
Hou, L; Jiang, L; Lu, X; Ma, P; Shi, Y; Yao, M; Zhang, P | 1 |
Feng, XD; Li, RQ; Wang, L; Zhang, Y; Zhang, YH | 1 |
Andreone, P; Gamal, N; Vitale, G | 1 |
Antonov, K; Atanasova, E; Boyanova, Y; Jelev, D; Krastev, Z; Mateva, L; Petkova, T; Tomov, B; Zheleva, N | 1 |
Johnson, S; Marx, SE; Misurski, D; Parisé, H; Saab, S; Sanchez Gonzalez, Y; Virabhak, S; Wang, A | 1 |
Gonzalez, YS; Johnson, S; Juday, T; Misurski, D; Parisé, H; Saab, S; Virabhak, S; Wang, A | 1 |
Alric, L; Anty, R; Beaulieux, F; Botta-Fridlund, D; Bouix, C; Canva, V; Carrieri, MP; Conti, F; D'Alteroche, L; Duclos-Vallée, JC; Durand, F; Duvoux, C; Fontaine, H; Lebray, P; Leroy, V; Maynard, M; Métivier, S; Pageaux, GP; Paul, C; Petrov-Sanchez, V; Pradat, P; Roche, B; Roque-Afonso, AM; Samuel, D; Vilotitch, A; Wellems, C | 1 |
Albillos, A; Ampuero, J; Arenas, J; Bañares, R; Calleja, JL; Crespo, J; Diago, M; Fernandez, I; García-Eliz, M; García-Samaniego, J; Gea, F; Jorquera, F; Lens, S; Llaneras, J; Llerena, S; Mariño, Z; Morillas, RM; Muñoz, R; Navascues, CA; Pascasio, JM; Perelló, C; Rincón, D; Rodriguez, CF; Ruiz-Antorán, B; Sacristán, B; Serra, MA; Simon, MA; Torras, X; Turnes, J | 1 |
Pár, A; Pár, G | 1 |
Feng, JL; Li, GP; Pu, ZJ; Su, JD; Wei, BL; Wu, LF; Ye, YQ | 1 |
Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW; Roomi, NW | 1 |
Bukh, J; Ghanem, L; Gottwein, JM; Jensen, TB; Scheel, TK | 1 |
Francque, S; Ho, E; Michielsen, P | 1 |
BAUER, JM; WU, C | 1 |
PERAINO, C; PITOT, HC | 1 |
Hsu, JM; Huang, CY; Lee, YC; Yu, CT | 1 |
Cong, WM; Dong, H; Liu, SF; Wu, MC; Zhu, GS; Zhu, ZZ | 1 |
Chi, KH; Chou, SL; Kao, SJ; Tseng, FW; Wang, HE; Wang, YS; Wu, HC; Yen, SH; Yu, HM | 1 |
Chen, Y; Ding, SS; Hu, P; Shi, PC; Wu, XZ | 1 |
Fan, ST; Kwong, YL; Lee, TK; Pang, R; Poon, RT; Tse, E; Wong, KB | 1 |
Lee, SJ; Lim, KT | 1 |
Gao, H; He, S; Tang, WX; Wang, J | 1 |
Kishimoto, T; Kokura, K; Kumagai, Y; Makino, Y; Tamura, T; Wakamatsu, T | 1 |
Kawasaki, T; Ma, Y; Shida, H | 1 |
Ando, A; Del Monte, MA; Ito, S; Maeda, H; Masu, Y; Ueda, M; Uyama, M | 1 |
Bartsch, H; Frank, N; Lin, JK; Liu, GY | 1 |
Bills, DD; Nixon, JE; Scanlan, RA; Sinnhuber, RO; Wales, JH | 1 |
Boutron, A; Goenner, S; Lemonnier, A; Moatti, N; Soni, T | 1 |
Easton, AJ; McLachlan, A; Milich, DR; Raney, AK | 1 |
Ichihara, A; Nakamura, T | 1 |
Bienkowski, RS; Wu, CH; Wu, GY | 1 |
Goldberg, B; Green, H | 2 |
Downing, SJ; Harris, SC; Phang, JM; Valle, D | 1 |
Hogan, BL; Murden, S | 1 |
4 review(s) available for proline and Carcinoma, Hepatocellular
Article | Year |
---|---|
New approaches in viraemic organ transplantation and antiviral therapies.
Topics: Aminoisobutyric Acids; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Guanine; Hepatitis B, Chronic; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Lactams, Macrocyclic; Leucine; Liver Neoplasms; Liver Transplantation; Macrocyclic Compounds; Proline; Quinoxalines; Salvage Therapy; Sofosbuvir; Sulfonamides; Tenofovir; Transplants | 2020 |
Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Virus Activation | 2014 |
ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Proline; Protease Inhibitors; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; RNA, Viral; Sulfonamides; Uracil; Valine | 2015 |
Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Europe; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Japan; Liver Neoplasms; North America; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Risk Assessment; Treatment Outcome; Viral Load | 2012 |
1 trial(s) available for proline and Carcinoma, Hepatocellular
Article | Year |
---|---|
Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Neoplasms; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2020 |
50 other study(ies) available for proline and Carcinoma, Hepatocellular
Article | Year |
---|---|
Stachydrine hydrochloride inhibits hepatocellular carcinoma progression via LIF/AMPK axis.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Mice; Molecular Docking Simulation; Proline | 2022 |
Metabolomics-based classification reveals subtypes of hepatocellular carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Glutamates; Humans; Liver Neoplasms; Metabolomics; Phosphates; Phosphatidylcholines; Phosphatidylethanolamines; Proline | 2022 |
Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines.
Topics: Alanine; Amino Acids; Antineoplastic Agents; Biomarkers; Calpain; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Folic Acid Antagonists; Glucose; Humans; L-Iditol 2-Dehydrogenase; Liver Neoplasms; Metabolic Networks and Pathways; Nucleotides; Phosphatidylcholines; Proline; Protein Kinase Inhibitors; Proteome; Proteomics; Sorafenib; Succinic Acid; Superoxide Dismutase; Tyrosine; Ubiquitin Thiolesterase; Uridine Diphosphate | 2022 |
Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
Topics: Carcinoma, Hepatocellular; Case-Control Studies; Glutamine; Histidine; Humans; Liver Neoplasms; Lysophosphatidylcholines; Male; Phosphatidylcholines; Proline; Prospective Studies; Risk Factors; Sphingomyelins | 2022 |
Transcriptome Analysis of Redox Systems and Polyamine Metabolic Pathway in Hepatoma and Non-Tumor Hepatocyte-like Cells.
Topics: Carcinoma, Hepatocellular; Gene Expression Profiling; Hepatocytes; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Oxidation-Reduction; Polyamines; Proline; Reactive Oxygen Species; Urea | 2023 |
Au(iii)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Carbamates; Carcinoma, Hepatocellular; Cell Line, Tumor; Coordination Complexes; Gold; Humans; Liver Neoplasms; Proline; Serpins | 2019 |
Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Topics: Aldehyde Dehydrogenase; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; delta-1-Pyrroline-5-Carboxylate Reductase; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HaCaT Cells; HEK293 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Mice, SCID; Proline; Pyrroline Carboxylate Reductases; Rats; Signal Transduction; Transcriptome; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Stachydrine inhibits TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-β/Smad and PI3K/Akt/mTOR signaling pathways.
Topics: Cadherins; Carcinoma, Hepatocellular; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Hep G2 Cells; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Proline; Signal Transduction; Smad2 Protein; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1; Vimentin | 2021 |
Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Cyclopropanes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Liver Neoplasms; Proline; Pyrrolidines; Quinoxalines; Sulfonamides | 2021 |
Successful twice interrupted therapy of HCV infection in patients with cirrhosis with hepatocellular carcinoma before and after liver transplantation.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Valine | 2017 |
Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Energy Metabolism; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Metabolome; Metabolomics; Phenotype; Proline; Sorafenib; Xenograft Model Antitumor Assays | 2018 |
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Poland; Proline; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load | 2018 |
Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice.
Topics: 2-Naphthylamine; Aged; Anilides; Antineoplastic Agents; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ritonavir; Sorafenib; Sulfonamides; Treatment Outcome; Uracil; Valine | 2018 |
Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclopropanes; Hepatectomy; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Middle Aged; Neoplasm Recurrence, Local; Proline; Prospective Studies; Radiofrequency Ablation; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2019 |
[Therapy of hepatitis C: new inhibitors as hammers against HCV].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Drugs, Investigational; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Oligopeptides; Proline; Protease Inhibitors | 2013 |
Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
Topics: Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Genotype; Hepacivirus; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Liver; Liver Neoplasms; Mutation; Oligopeptides; Proline; Protease Inhibitors; Pyrrolidines; Valine; Viral Nonstructural Proteins | 2014 |
Liver transplantation in a child with multifocal hepatocellular carcinoma hepatitis C and management of post-transplant viral recurrence using boceprevir.
Topics: Adolescent; Carcinoma, Hepatocellular; Child; Graft Survival; Hepatitis C; Humans; Interferons; Liver Neoplasms; Liver Transplantation; Male; Polyethylene Glycols; Postoperative Complications; Proline; Recurrence; Ribavirin; Severe Combined Immunodeficiency | 2014 |
NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Cyclin D1; Estradiol; Hep G2 Cells; Humans; Interleukin-6; Liver Neoplasms; Male; NF-kappa B; Peroxisomal Multifunctional Protein-2; Proliferating Cell Nuclear Antigen; Proline; Promoter Regions, Genetic; Thiocarbamates; Tumor Necrosis Factor-alpha; Up-Regulation | 2015 |
Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Down-Regulation; Gene Expression Regulation; Genes, Reporter; Hep G2 Cells; Humans; Liver Neoplasms; NF-kappa B; Proline; Promoter Regions, Genetic; PTEN Phosphohydrolase; RNA, Messenger; Signal Transduction; Thiocarbamates; Transfection; Viral Core Proteins | 2014 |
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Macrocyclic Compounds; Male; Proline; Ribavirin; Ritonavir; RNA, Viral; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load | 2016 |
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.
Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Fibrosis; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Markov Chains; Middle Aged; Models, Econometric; Proline; Quality-Adjusted Life Years; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uracil; Valine | 2016 |
Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Markov Chains; Middle Aged; Polyethylene Glycols; Proline; Quality-Adjusted Life Years; Recombinant Proteins; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; United States; Uracil; Valine | 2016 |
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).
Topics: Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; France; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Proline; Quality of Life; Retrospective Studies; Ribavirin; Treatment Outcome | 2017 |
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.
Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Fluorenes; Genotype; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Neoplasm Recurrence, Local; Proline; Retrospective Studies; Ribavirin; Ritonavir; Sofosbuvir; Spain; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Uridine Monophosphate; Valine; Young Adult | 2017 |
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Delayed-Action Preparations; Europe; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Niacinamide; Oligopeptides; Patient Compliance; Phenylurea Compounds; Polyethylene Glycols; Proline; Pyridines; Recombinant Proteins; Ribavirin; Societies, Medical; Sorafenib | 2008 |
Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Topics: Adenosine; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Extracellular Space; Hep G2 Cells; Humans; Liver Neoplasms; NF-kappa B; Proline; Thiocarbamates | 2010 |
In vivo and In vitro effect of a nutrient mixture on human hepatocarcinoma cell line SK-HEP-1.
Topics: Animals; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Camellia sinensis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Humans; Liver Neoplasms; Lysine; Male; Matrix Metalloproteinases; Mice; Mice, Nude; Neoplasms, Experimental; Plant Extracts; Proline; Tea; Xenograft Model Antitumor Assays | 2010 |
Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses.
Topics: Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Cyclopropanes; Genotype; Hepacivirus; Hepatitis C; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Isoindoles; Lactams; Lactams, Macrocyclic; Leucine; Liver Neoplasms; Molecular Sequence Data; Oligopeptides; Proline; Protease Inhibitors; Sulfonamides; Treatment Outcome; Viral Nonstructural Proteins | 2011 |
PEPITASE ACTIVITIES IN TISSUES OF TUMOR-BEARING RATS.
Topics: Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Erythrocytes; Glycine; Leucine; Liver; Liver Neoplasms; Muscles; Neoplasms; Neoplasms, Experimental; Peptide Hydrolases; Peptides; Proline; Rats; Research; Sarcoma; Sarcoma, Experimental | 1963 |
Proline synthesis and degradation in a minimal deviation hepatoma.
Topics: Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Liver Neoplasms, Experimental; Proline | 1962 |
Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region.
Topics: Amino Acid Motifs; Amino Acid Sequence; Binding Sites; Blotting, Western; Carcinoma, Hepatocellular; CDC2 Protein Kinase; Cell Cycle; Cell Line; Cyclin B; Cycloheximide; Databases as Topic; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; F-Box Proteins; Genetic Vectors; Humans; Microscopy, Fluorescence; Mitosis; Models, Biological; Models, Genetic; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Neoplasm Proteins; Nocodazole; Phosphoproteins; Phosphorylation; Precipitin Tests; Proline; Protein Binding; Protein Biosynthesis; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Recombinant Proteins; Recombination, Genetic; RNA, Small Interfering; Sequence Homology, Amino Acid; Stem Cell Factor; Substrate Specificity; Temperature; Time Factors; Transfection; Ubiquitin | 2004 |
Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
Topics: Amino Acid Substitution; Arginine; Base Sequence; Carcinoma, Hepatocellular; China; DNA Primers; Gene Frequency; Humans; Liver Neoplasms; Mutation, Missense; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proline; Risk Factors; Tumor Suppressor Protein p53 | 2005 |
Modulation of 5-fluorouracil cytotoxicity through thymidylate synthase and NF-kappaB down-regulation and its application on the radiolabelled iododeoxyuridine therapy on human hepatoma cell.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Fluorouracil; Humans; Idoxuridine; Iodine Radioisotopes; Liver Neoplasms; NF-kappa B; Phenylbutyrates; Proline; Thiocarbamates; Thymidylate Synthase | 2005 |
N-all-trans-retinoyl-L-proline inhibits metastatic potential of hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Adhesion; Cell Cycle; Cell Movement; Fenretinide; Fucose; Fucosyltransferases; Gelatinases; Humans; Liver Neoplasms, Experimental; Mice; Mice, Nude; Molecular Structure; Neoplasm Invasiveness; Neoplasm Transplantation; Proline; Receptors, Retinoic Acid; Tretinoin; Tumor Cells, Cultured | 2006 |
Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Topics: Amino Acid Motifs; Animals; bcl-X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Hepatitis B; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Nude; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Phosphorylation; Proline; Protein Binding; Proto-Oncogene Proteins c-myc; Reproducibility of Results; RNA, Messenger; Serine; Trans-Activators; Transcription Factor RelA; Transcription, Genetic; Transcriptional Activation; Transfection; Transplantation, Heterologous; Up-Regulation; Viral Regulatory and Accessory Proteins | 2007 |
Cell death signal by glycine- and proline-rich plant glycoprotein is transferred from cytochrome c and nuclear factor kappa B to caspase 3 in Hep3B cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; DNA; Enzyme Activation; Glycine; Glycoproteins; Humans; Liver Neoplasms; Mitochondria, Liver; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Proteins; Poly(ADP-ribose) Polymerases; Proline; Reactive Oxygen Species; Signal Transduction | 2008 |
[Inhibition of NF-kappa B activity enhanced apoptosis induced by matrine in hepatocellular carcinoma cells].
Topics: Alkaloids; Apoptosis; Carcinoma, Hepatocellular; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Matrines; NF-kappa B; Proline; Quinolizines; Thiocarbamates | 2007 |
HTF: A b-ZIP transcription factor that is closely related to the human XBP/TREB5 and is activated by hepatocellular carcinoma in rats.
Topics: Amino Acid Sequence; Animals; Base Sequence; Basic-Leucine Zipper Transcription Factors; Binding Sites; Carcinoma, Hepatocellular; Cloning, Molecular; DNA-Binding Proteins; DNA, Complementary; Glutamine; Humans; Leucine Zippers; Liver; Liver Neoplasms; Molecular Sequence Data; Neoplasm Proteins; Nuclear Proteins; Oligodeoxyribonucleotides; Open Reading Frames; Proline; Rats; Recombinant Proteins; Regulatory Factor X Transcription Factors; RNA, Messenger; Transcription Factors; Transcription, Genetic; X-Box Binding Protein 1 | 1996 |
Functional expression of human mannan-binding proteins (MBPs) in human hepatoma cell lines infected by recombinant vaccinia virus: post-translational modification, molecular assembly, and differentiation of serum and liver MBP.
Topics: Aged; Amino Acid Sequence; Animals; Biopolymers; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line; Cloning, Molecular; Collagen; Collectins; Complement Activation; COS Cells; Humans; Hydroxylation; Liver; Lysine; Male; Mannans; Molecular Sequence Data; Proline; Protein Processing, Post-Translational; Rabbits; Recombination, Genetic; Tumor Cells, Cultured; Vaccinia virus | 1997 |
Prevention of ornithine cytotoxicity by proline in human retinal pigment epithelial cells.
Topics: Arginine; Carcinoma, Hepatocellular; Cell Death; Cell Division; Cell Line; Cell Survival; DNA; DNA Replication; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluorescent Antibody Technique, Indirect; Humans; Keratins; Liver Neoplasms; Ornithine; Ornithine-Oxo-Acid Transaminase; Pigment Epithelium of Eye; Proline | 1998 |
Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NFkappaB, c-fos/c-jun, and p53 proteins.
Topics: Alcohol Deterrents; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Disulfiram; Ditiocarb; G1 Phase; Humans; Microtubule-Associated Proteins; NF-kappa B; Oxidation-Reduction; Proline; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Thiocarbamates; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 1998 |
Null carcinogenic effect of large doses of nitrosoproline and nitrosohydroxyproline in Wistar rats.
Topics: Animals; Carcinoma, Hepatocellular; Dimethylnitrosamine; Drug Synergism; Fatty Acids, Unsaturated; Hydroxyproline; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Experimental; Nitrosamines; Proline; Rats | 1976 |
Amino acid transport systems in the human hepatoma cell line Hep G2.
Topics: Alanine; Amino Acids; Biological Transport; Carcinoma, Hepatocellular; Humans; Kinetics; Lithium; Liver Neoplasms; Proline; Serine; Sodium; Tumor Cells, Cultured | 1992 |
Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1.
Topics: Animals; Antigens, Surface; Antigens, Viral; Base Sequence; Binding Sites; Carcinoma, Hepatocellular; Cell Line; DNA-Binding Proteins; Genetic Vectors; Genome, Viral; Glutamine; Hepatitis B virus; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Humans; Liver Neoplasms; Molecular Sequence Data; Nuclear Proteins; Oligodeoxyribonucleotides; Plasmids; Proline; Promoter Regions, Genetic; Rats; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 1991 |
Control of growth and expression of differentiated functions of mature hepatocytes in primary culture.
Topics: Animals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Division; Cell Membrane; Cells, Cultured; Contact Inhibition; DNA Replication; Epidermal Growth Factor; Gene Expression Regulation; Growth Substances; Insulin; Liver; Liver Neoplasms; Liver Regeneration; Proline; Rats; Tryptophan Oxygenase | 1985 |
Limitation on sensitivity of measuring collagen degradation: studies with cultured liver cells.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Collagen; Humans; Hydroxyproline; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Molecular Weight; Proline; Rats; Rats, Inbred Strains | 1986 |
The synthesis of collagen and protocollagen hydroxylase by fibroblastic and nonfibroblastic cell lines.
Topics: Animals; Burkitt Lymphoma; Carcinoma, Hepatocellular; Collagen; Culture Techniques; Fibroblasts; HeLa Cells; Humans; Liver Neoplasms; Mice; Mixed Function Oxygenases; Neoplasms, Experimental; Proline; Tritium | 1968 |
Relation between collagen synthesis and collagen proline hydroxylase activity in mammalian cells.
Topics: Animals; Carcinoma, Hepatocellular; Clone Cells; Collagen; Culture Techniques; Fibroblasts; HeLa Cells; Humans; Hydroxyproline; Kinetics; L Cells; Liver Neoplasms; Lymphocytes; Mixed Function Oxygenases; Proline; Rabbits; Reticulocytes; Tritium | 1969 |
Proline biosynthesis: multiple defects in Chinese hamster ovary cells.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Cricetinae; Female; Fibroblasts; Glutamates; Humans; Liver Neoplasms; Lung; Male; Ornithine; Ovary; Proline; Rats; Transaminases | 1973 |
Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. I. Effect of amino acid supply.
Topics: Amino Acids; Animals; Arginine; Asparagine; Carbon Radioisotopes; Carboxy-Lyases; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Culture Media; Cycloheximide; Drug Synergism; Glutamine; Glycine; Immune Sera; Leucine; Liver Neoplasms; Neoplasm Proteins; Ornithine; Proline; Pyridoxal; Rats; Serine; Stimulation, Chemical; Time Factors | 1974 |